Home › Rare Diseases › Ohio › Cincinnati
Rare Diseases clinical trials in Cincinnati, OH
5 studies for Rare Diseases are looking for participants at sites in and around Cincinnati (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
International Rare Brain Tumor Registry
RecruitingObservational study
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
RecruitingPhase 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
RecruitingPhase 1/2
- University of Cincinnati/Cincinnati Children's Hospital, Cincinnati
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
RecruitingPhase 2
- University of Cincinnati, Cincinnati
Epilepsy Learning Healthcare System (ELHS)
RecruitingObservational study
- Cincinnati Children's Hospital Comprehensive Epilepsy Center (CCHMC), Cincinnati
- University of Cincinnati Gardner Neuroscience Institute Epilepsy Center, Cincinnati
About Rare Diseases
A rare disease is one that affects fewer than 200,000 people in the United States. There are nearly 7,000, affecting more than 25 million Americans.
More about Rare Diseases on MedlinePlus
Rare Diseases trials in other cities
- Boston, MA9 studies
- Washington, DC8 studies
- Chicago, IL8 studies
- Philadelphia, PA7 studies
- Los Angeles, CA5 studies
- Columbus, OH4 studies
- Pittsburgh, PA3 studies
- Atlanta, GA3 studies
- New York City, NY3 studies
- Seattle, WA3 studies
- Durham, NC3 studies
- St. Louis, MO3 studies
Other studies in Cincinnati
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)26 studies
- Breast Cancer24 studies
- Heart Failure22 studies
- Metastatic Cancer21 studies
- Colorectal Cancer20 studies
- Obesity20 studies
- Acute Myeloid Leukemia20 studies
- Prostate Cancer19 studies
- Ovarian Cancer18 studies
- Lung Cancer18 studies
- Multiple Myeloma17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.